Dennis P Heller, Ph.D.

In his current role with Certara, Dr. Heller provides consultancy services and project team support to pharmaceutical and biotech companies in the areas of non-clinical and clinical ADME/DMPK, bioanalysis, radiolabel study design and dosimetry estimations.

Dr. Heller has over 20 years’ experience providing scientific/technical leadership, technical sales/consultancy and operational management in the CRO environment to enable a platform of ADME and bioanalytical services, with depth in radiolabel studies from in vitro, non-clinical to clinical hAME studies and dosimetry.

Prior to moving to industry, Dr. Heller was Assistant Professor, Department of Radiology, Division of Radiation Oncology at the University of Cincinnati, Ohio where he taught graduate courses in radiation biology conducted research into the mechanisms of radiation resistance of cancer cells.

Dr. Heller received his B.Sc. in Physics from the University of Waterloo, M.Sc. in Medical Physics from the University of Manitoba, and Ph.D. in Medical Physics/Radiation Biology from Carleton University all in Canada.